CYP2C19 genotypes in Germany and influence on treatment of Helicobacter pylori infection

被引:2
|
作者
Kirsch, C
Schneider-Brachert, W
Grossmann, D
Stolte, M
Lehn, N
Miehlke, S
机构
关键词
D O I
10.1016/S0016-5085(03)80897-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A180 / A180
页数:1
相关论文
共 50 条
  • [41] Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes
    Li-Jun Yang
    Lan Fan
    Zhao-Qian Liu
    Yan-Mei Mao
    Dong Guo
    Li-Hui Liu
    Zhi-Rong Tan
    Liang Peng
    Chun-Ting Han
    Dong-Li Hu
    Dan Wang
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2009, 65 : 601 - 608
  • [42] EFFECTS OF ALLICIN ON CYP2C19 AND CYP3A4 ACTIVITY IN HEALTHY VOLUNTEERS WITH DIFFERENT CYP2C19 GENOTYPES
    Yang, Li-Jun
    Zhou, Hong-Hao
    DRUG METABOLISM REVIEWS, 2008, 40 : 35 - 35
  • [43] Influence of CYP2C19 Genetic Polymorphisms and Helicobacter pylori Infection on Efficacy of Omeprazole Treatment in Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding: A Prospective, Randomized Clinical Study
    Chwiesko, Adam
    Charkiewicz, Radoslaw
    Niklinski, Jacek
    Milewski, Robert
    Dabrowski, Andrzej
    GASTROENTEROLOGY, 2013, 144 (05) : S506 - S506
  • [44] CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection
    Sagar, M
    Seensalu, R
    Tybring, G
    Dahl, ML
    Bertilsson, L
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (10) : 1034 - 1038
  • [45] Effect of clarithromycin resistance and CYP2C19 polymorphism on the efficacy of therapies for helicobacter pylori infection in chilean people: Cohort study
    Rojas Orellana, Luis
    Arenas, Alex
    Riquelme, Arnoldo
    Serrano, Carolina
    Quinones, Luis
    Harris, Paul
    Sandoval, Mauricio
    Lavanderos, Maria
    Jorquera, Andres
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 17 - 18
  • [46] EFFECT OF CLARITHROMYCIN RESISTANCE AND CYP2C19 POLYMORPHISM ON THE EFFICACY OF THERAPIES FOR HELICOBACTER PYLORI INFECTION IN CHILEAN PEOPLE: COHORT STUDY
    Arenas, A.
    Serrano, C.
    Quinones, L.
    Harris, P.
    Sandoval, M.
    Lavanderos, M.
    Sepulveda, R.
    Maquilon, S.
    Echeverria, A.
    Rios, C.
    Rojas, L.
    Jorquera, A.
    Pizarro, M.
    Camargo, C.
    Riquelme, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 81 - 81
  • [47] Effect of cyp2c19 polymorphism on the eradication rate of Helicobacter pylori infection by pantoprazole or esomeprazole based triple therapy in Korea
    Kang, Jung mook
    Kim, Nayoung
    Kim, Joo sung
    Jung, Hyun chae
    Song, In sung
    GASTROENTEROLOGY, 2007, 132 (04) : A613 - A613
  • [48] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Zalloum, Imad
    Hakooz, Nancy
    Arafat, Tawfiq
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4195 - 4200
  • [49] Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
    Imad Zalloum
    Nancy Hakooz
    Tawfiq Arafat
    Molecular Biology Reports, 2012, 39 : 4195 - 4200
  • [50] Influence of Abcb1 and Cyp 2c19 Polymorphisms On Rescue Therapy of Helicobacter pylori Infection
    Knauff, Laura K.
    Berning, Marco
    Kirsh, Christian
    Schneider-Brachert, Wulf
    Miehlke, Stephan
    GASTROENTEROLOGY, 2009, 136 (05) : A344 - A344